WQ
VIVO

Wealth Quarterback’s Meridian Bioscience Inc VIVO Stock Holding History

Wealth Quarterback’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-115
Closed -$3K – 895
2021
Q2 		$3K Buy
+115
New +$2.44K ﹤0.01% 723

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Wealth Quarterback's VIVO Position: Q3 2021 in Review

Wealth Quarterback sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 115 shares — an estimated $3K sold.

Wealth Quarterback first reported a position in VIVO in Q2 2021 and held it in 1 quarter. The position peaked at $3K in Q2 2021. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.

  • Wealth Quarterback reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
  • Wealth Quarterback sold 115 Meridian Bioscience Inc shares in Q3 2021, an estimated $3K.
  • Wealth Quarterback first reported a position in Meridian Bioscience Inc in Q2 2021 and held it in 1 quarter.
  • Wealth Quarterback's Meridian Bioscience Inc position peaked at $3K in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.